Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email Cadwalader advised Corindus Vascular Robotics, Inc. (NYSE American: CVRS) on its acquisition by a subsidiary of Siemens Healthineers AG in a transaction valued at $1.1 billion. https://www.cadwalader.com/news/news-release/cadwalader-advises-corindus-vascular-robotics-on-acquisition-by-siemens-healthineers-ag